Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 39Ovarian Neoplasms 32Triple Negative Breast Neoplasms 19Prostatic Neoplasms 17Fallopian Tube Neoplasms 16Neoplasm Metastasis 14Pancreatic Neoplasms 9Neoplasms 9Endometrial Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Small Cell Lung Carcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Glioma 6Stomach Neoplasms 5Sarcoma 5Lung Neoplasms 5Glioblastoma 5Squamous Cell Carcinoma of Head and Neck 4Metastatic Castration-resistant Prostate Cancer 4Carcinoma, Ovarian Epithelial 4Solid Tumors 3Recurrence 3Osteosarcoma 3Neuroendocrine Tumors 3Lymphoma, Non-Hodgkin 3Cholangiocarcinoma 3Urinary Bladder Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Prostatic Neoplasms, Castration-Resistant 2

Interventions

Gemcitabine 11Cisplatin 10pembrolizumab 5Oxaliplatin 4durvalumab 3Magnetic Resonance Spectroscopy 3Leucovorin 3Fluorouracil 3tivozanib 2Specimen Handling 2Capecitabine 2zimberelimab 1trametinib 1tislelizumab 1quemliclustat 1pertuzumab 1olaparib 1irinotecan sucrosofate 1atezolizumab 1anlotinib 1Yttrium-90 1Tissue Adhesives 1Tegafur 1Stents 1S 1 (combination) 1Ritonavir 1Radiosurgery 1Pancreaticojejunostomy 1Pancreaticoduodenectomy 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bile Duct Neoplasms × olaparib × 1 year × Clear all
NCT04042831 2026-05-15

Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

Academic and Community Cancer Research United

Phase 2 Active not recruiting
32 enrolled 15 charts
Gastrointestinal

Bile Duct Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡